Shenzhen Wenjin Biotechnology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Wenjin Biotechnology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include UNISINEW. The owner is based in Longhua Dist, Shenzhen.

No. 158 Xinzhang Rd, Zhangxi, Guanhu St,

Rm 3A, Blk E, Zhongsen Park Huafu,

Longhua Dist, Shenzhen 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

UNISINEW
UNISINEW
Registered 2024

Trademark Classifications

Shenzhen Wenjin Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Shenzhen Wenjin Biotechnology Co., Ltd. have?

Shenzhen Wenjin Biotechnology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Wenjin Biotechnology Co., Ltd. file in?

Shenzhen Wenjin Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Shenzhen Wenjin Biotechnology Co., Ltd.'s most well-known trademarks?

Shenzhen Wenjin Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as UNISINEW. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Wenjin Biotechnology Co., Ltd.'s trademark registration success rate?

Shenzhen Wenjin Biotechnology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.